Bristol-Myers Squibb Medical Imaging and Kereos have agreed to partner in the development and commercialization of novel molecular imaging agents. The goal is to develop agents that will detect disease on a molecular level, potentially enabling earlier
Bristol-Myers Squibb Medical Imaging and Kereos have agreed to partner in the development and commercialization of novel molecular imaging agents. The goal is to develop agents that will detect disease on a molecular level, potentially enabling earlier and more effective diagnosis and highly targeted treatment of cardiovascular diseases and cancer. The companies will work together to develop molecular imaging agents using Kereos' core technology. BMS Medical Imaging has obtained exclusive worldwide rights to develop and commercialize select cardiovascular molecular imaging agents for MR. Kereos has obtained exclusive worldwide rights to use a family of BMS targeting molecules with Kereos' core technology to develop and commercialize imaging agents and targeted therapeutics. These include KI-001, Kereos' lead candidate for early MR detection of tumors. In addition to working with BMS, Kereos is collaborating with Philips Medical Systems for the development of molecular imaging systems.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.